Siga Technologies (SIGA) Cash from Financing Activities (2010 - 2025)
Siga Technologies (SIGA) reported Cash from Financing Activities of -$403480.0 for Q3 2025, down 47.18% on a YoY basis from -$763943.4 in Q3 2024, and up 99.06% quarter-over-quarter from -$42.9 million in Q2 2025.
Siga Technologies (SIGA) Cash from Financing Activities (2010 - 2025) Analysis & Trends
Siga Technologies has reported Cash from Financing Activities for 16 years, with the latest figure at -$403480.0 in Q3 2025.
- For the quarter ending Q3 2025, Cash from Financing Activities fell 47.18% year-over-year to -$403480.0; the trailing twelve-month figure through Sep 2025 stood at -$43.6 million (down 0.74% YoY), and the FY2024 full-year result was -$43.5 million, changed 0.1% from the prior year.
- Cash from Financing Activities for Q3 2025 stood at -$403480.0, up from -$42.9 million in the prior quarter.
- The five-year high for Cash from Financing Activities was -$158980.0 in Q1 2024, with the low at -$42.9 million in Q2 2025.
- Historically, Cash from Financing Activities has averaged -$12.7 million across 5 years, with a median of -$6.6 million in 2021.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities tumbled 453.31% — and 2024, when it jumped 97.9%.
- Siga Technologies' Cash from Financing Activities stood at -$5.8 million in 2021, then jumped by 50.45% to -$2.9 million in 2022, then slumped by 1157.24% to -$35.9 million in 2023, then surged by 99.55% to -$161756.0 in 2024, then plunged by 149.44% to -$403480.0 in 2025.
- The last three Cash from Financing Activities figures came in at -$403480.0 (Q3 2025), -$42.9 million (Q2 2025), and -$166193.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -840.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1.48 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -86.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -65.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.47 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -77.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -11.62 Mn |
| 10 | Siga Technologies | 314.73 Mn | 159.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -403,480.00 |
| Sep 30, 2025 | -403,480.00 |
| Jun 30, 2025 | -42.89 Mn |
| Jun 30, 2025 | -42.89 Mn |
| Mar 31, 2025 | -166,193.00 |
| Mar 31, 2025 | -166,193.00 |
| Dec 31, 2024 | -161,756.00 |
| Dec 31, 2024 | -161,756.00 |
| Sep 30, 2024 | -274,132.00 |
| Sep 30, 2024 | -274,132.00 |
| Jun 30, 2024 | -42.87 Mn |
| Jun 30, 2024 | -42.87 Mn |
| Mar 31, 2024 | -158,980.00 |
| Mar 31, 2024 | -158,980.00 |
| Jun 30, 2023 | -35.87 Mn |
| Jun 30, 2023 | -35.87 Mn |
| Mar 31, 2023 | -7.56 Mn |
| Mar 31, 2023 | -7.56 Mn |
| Dec 31, 2022 | -2.85 Mn |
| Dec 31, 2022 | -2.85 Mn |